iBio Inc.
News
iBio to Participate in Upcoming Investor Conferences
Globe Newswire SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO), an AI-driven innovator of precision antibody immunotherapies, announced today that CEO and Chief Scientific Officer, Martin...\n more…
iBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of Business Development
Globe Newswire Life sciences industry veteran to lead strategic alliances for iBio's machine learning platform for antibody discovery and pipeline of cardiometabolic targetsSAN DIEGO, Aug. 12, 2024 (GLOBE...\n more…
iBio Closes Sale of Manufacturing Facility in Texas
Globe Newswire The sale of the facility eliminates $13.2M of secured debt Completes iBio's transition to an AI and precision biologics innovation company - SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- iBio...\n more…
iBio Appoints Dr. Martin Brenner as CEO, Felipe Duran as CFO to Oversee Company's Next Stage of Growth
Globe Newswire Board appointments solidify management team to lead iBios AI-powered biotech strategy BRYAN, Texas and SAN DIEGO, June 27, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (iBio or the Company), an AI-driven innovator of precision antibody immunotherapies, today announced the appointments of Martin ...\n more…
iBio Forges Research Collaboration with the National Institutes of Health
Globe Newswire NIH to evaluate iBios patented AI-driven epitope steering platform for Lassa fever vaccine development BRYAN, Texas and SAN DIEGO, June 12, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (iBio or the Company), an AI-driven innovator of precision antibody immunotherapies, today announced that the ...\n more…
iBio Expands Tech Stack with EngageTx'"; Adds TROP-2 Bispecific to Development Pipeline
Globe Newswire BRYAN, Texas and SAN DIEGO, June 06, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (iBio or the Company) today announced the expansion of its AI-powered technology stack with the launch of EngageTx, a proprietary T-cell engager antibody panel designed for developing bispecific antibodies for ...\n more…